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Abstract 
Background: Left ventricular (LV) diastolic dysfunction is highly prevalent in the general population and associated 
with a significant morbidity and mortality. Its prognostic role in patients sustaining septic shock in the intensive care 
unit (ICU) remains controversial. Accordingly, we investigated whether LV diastolic function was independently associ‑
ated with ICU mortality in a cohort of septic shock patients assessed using critical care echocardiography.
Methods: Over a 5‑year period, patients hospitalized in a Medical–Surgical ICU who underwent an echocardio‑
graphic assessment with digitally stored images during the initial management of a septic shock were included in this 
retrospective single‑center study. Off‑line echocardiographic measurements were independently performed by an 
expert in critical care echocardiography who was unaware of patients’ outcome. LV diastolic dysfunction was defined 
by the presence of a lateral E′ maximal velocity <10 cm/s. A multivariate analysis was performed to determine inde‑
pendent risk factors associated with ICU mortality.
Results: Among the 540 patients hospitalized in the ICU with septic shock during the study period, 223 were studied 
(140 men [63 %]; age 64 ± 13 years; SAPS II 55 ± 18; SOFA 10 ± 3; Charlson 3.5 ± 2.5) and 204 of them (91 %) were 
mechanically ventilated. ICU mortality was 35 %. LV diastolic dysfunction was observed in 31 % of patients. The pro‑
portion of LV diastolic dysfunction tended to be higher in non‑survivors than in their counterparts (28/78 [36 %] vs. 
41/145 [28 %]: p = 0.15). Inappropriate initial antibiotic therapy (OR 4.17 [CI 95 % 1.33–12.5]: p = 0.03), maximal dose 
of vasopressors (OR 1.38 [CI 95 % 1.16–1.63]: p = 0.01), SOFA score (OR 1.16 [CI 95 % 1.02–1.32]: p = 0.02) and lateral 
E′ maximal velocity (OR 1.12 [CI 95 % 1.01–1.24]: p = 0.02) were independently associated with ICU mortality. After 
adjusting for the SAPS II score, inappropriate initial antibiotic therapy and maximal dose of vasopressors remained 
independent factors for ICU mortality, whereas a trend was only observed for lateral E′ maximal velocity (OR 1.11 [CI 
95 % 0.99–1.23]: p = 0.07).
Conclusion: The present study suggests that LV diastolic function might be associated with ICU mortality in patients 
with septic shock. A multicenter prospective study assessing a large cohort of patients using serial echocardiographic 
examinations remains required to confirm the prognostic value of LV diastolic dysfunction in septic shock.
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Background
Septic shock remains the leading cause of death in the 
intensive care unit (ICU), with an increasing incidence 
and a current mortality of approximately 30  % [1–3]. 
Many experimental and clinical studies extensively docu-
mented the presence of a reversible sepsis-induced car-
diomyopathy which involves the systolic and diastolic 
functions of both ventricles [4–7]. The pathophysiology 
of septic cardiomyopathy is complex [8], and its prognos-
tic impact remains controversial [9–11].
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Heart failure with preserved ejection fraction is highly 
prevalent in the general population and associated with 
a high morbidity and mortality [12, 13]. In ICU patients, 
left ventricular (LV) diastolic dysfunction is frequently 
depicted using Doppler echocardiography [14]. Spe-
cifically, reversible abnormal LV relaxation has been 
reported during the early phase of septic shock [15, 16]. 
A recent meta-analysis suggests that LV diastolic dys-
function is associated with the mortality of severe sepsis 
and septic shock [17]. However, this meta-analysis suf-
fered from substantial limitations. First, the size of study 
populations varied greatly, leading to a wide range of 
prevalence of LV diastolic dysfunction (20–57  %). Sec-
ond, two cohorts involved two-third of the global popula-
tion included in the meta-analysis and were enrolled by 
the same investigating center [9, 18]. Third, the studied 
population was heterogeneous since patients were hemo-
dynamically assessed for either a severe sepsis or a septic 
shock [17]. Accordingly, we sought to assess the poten-
tial impact of LV diastolic function on ICU survival in a 
population of septic shock patients, with respect to other 
known prognostic factors.
Methods
This descriptive, retrospective, single-center study was 
approved by our institutional ethics committee which 
waived the need for informed consent.
Study population
Patients were eligible if (1) they were hospitalized in the 
Medical–Surgical ICU of Limoges University Hospi-
tal between December 2009 and December 2014 with a 
septic shock; (2) they were hemodynamically assessed 
using transthoracic (TTE) or transesophageal echocar-
diography (TEE) within the first 24  h of shock, and (3) 
digital recording of the echocardiographic examination 
was available for off-line measurements. Patients’ char-
acteristics on ICU admission, comorbidities assessed 
by the Charlson’s score [19] and severity scores includ-
ing the Simplified Acute Physiology Score (SAPS) II 
score [20] and the Sequential Organ Failure Assessment 
(SOFA) score [21] were recorded. In each patient, the fol-
lowing information was retrieved from electronic medi-
cal records or paper charts, as required: site of infection, 
time lag between the development of septic shock and 
the first administration of antibiotic therapy, appropri-
ateness of initial antibiotic therapy and volume of fluids 
administered prior to hemodynamic assessment. During 
the ICU stay, the following parameters were recorded: 
maximal dose of catecholamines, use of substitutive ster-
oids therapy, invasive mechanical ventilation and renal 
replacement therapy. At the time of septic shock diag-
nosis, the following biological values were obtained: pH, 
PaO2/FiO2 ratio, lactate, platelet count, serum creatinine, 
bilirubin, alanine aminotransferase and the presence of a 
disseminated intravascular coagulation [22]. Dobutamine 
was administered in the presence of severe LV systolic 
dysfunction without fluid responsiveness but persisting 
signs of tissue hypoperfusion, and no patient received 
beta-blockers, milrinone or levosimendan.
Definitions
Sepsis was defined by the presence of at least two criteria 
of systemic inflammatory response syndrome associated 
with a clinically or microbiologically documented, or a 
highly suspected infection. Severe sepsis was defined as 
a sepsis associated with at least one organ failure differ-
ent from that responsible for the infection. Septic shock 
was defined as a severe sepsis associated with low blood 
pressure despite adequate vascular filling which required 
a vasopressor support [23, 24]. The onset of septic shock 
was defined by the time of the first occurrence of recur-
rent or persistent hypotension (systolic blood pressure 
<90 mmHg or mean blood pressure <65 mmHg) despite 
adequate fluid loading (i.e., at least 30  mL/kg) [24]. 
Appropriateness of initial antibiotic therapy referred to 
the susceptibility of isolated microorganism rather than 
the time lag prior to its initiation. Previously determined 
rules to evaluate appropriateness of initial antibiotic 
therapy have been followed [25, 26]. Antibiotic therapy 
was considered appropriate if the first-line treatment 
included at least one antibiotic active in  vitro on the 
isolated microorganism. When no microorganism was 
found, the antibiotic therapy was considered appropriate 
if it was in accordance with broadly accepted guidelines 
for the expected site infection [25]. This information was 
recorded by an independent investigator who was una-
ware of patients’ outcome.
Echocardiography
Hemodynamic assessment was performed by experi-
enced intensivists highly trained in critical care echo-
cardiography [27]. We perform TEE examination in all 
ventilated patients with septic shock and no contrain-
dication for esophageal intubation, in conjunction with 
TTE for tissue Doppler assessment as a standard of care. 
All measurements were performed on a dedicated work-
station (Xcelera™, Philips) by an independent expert who 
was unaware of patients’ data and outcome.
In the four-chamber view, the following echocardio-
graphic parameters were measured: LV ejection fraction 
(EF) calculated conventionally from both the LV end-
diastolic volume (LVEDV) and LV end-systolic volume 
(LVESV) using the monoplane modified Simpson’s rule 
[28]; maximal velocity of mitral Doppler E and A waves 
recorded at the tip of valvular leaflets, and E/A ratio (sinus 
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rhythm); tissue Doppler imaging E′ wave maximal veloc-
ity measured on the lateral mitral annulus, and lateral E/E′ 
ratio [29]; right ventricular (RV) and LV end-diastolic area 
ratio (RVEDA/LVEDA) [30]. Pulse wave Doppler veloc-
ity–time integral of LV outflow tract (LVOT VTI) was 
measured in the apical five-chamber view or in the 120° 
transgastric view to indirectly assess LV stroke volume. 
The collapsibility index of the superior vena cava (ΔSVC) 
was measured using TEE M-mode in the long-axis view 
of the great vessels to assess fluid responsiveness [31]. A 
potential paradoxical motion of the interventricular sep-
tum was identified in the short-axis view of the heart. Its 
association with RV dilatation (i.e., RVEDA/LVEDA > 0.6) 
defined acute cor pulmonale [30].
LV diastolic dysfunction was defined by the presence 
of a lateral E′ maximal velocity <10 cm/s [32]. LV dilata-
tion was defined by an indexed LV end-diastolic volume 
(LVEDVi) >75 ml/m2, irrespective of gender [28].
Statistical analysis
Results are presented as means  ±  standard deviations 
and percentages. Quantitative variables were compared 
between patients who died in the ICU and patients who 
were discharged alive using Student’s t test or Mann and 
Whitney’s test when data were not normally distributed. 
Qualitative variables were compared between groups 
using the χ2 test or Fisher’s exact test, when necessary.
A stepwise multivariate logistic regression analysis was 
performed to identify independent variables associated 
with ICU mortality. All variables with a p value <0.20 
in the univariate analysis were incorporated into the 
model. The significance of parameters which remained 
in the final model was tested after adjusting for the SAPS 
II score. Odds ratio and their 95  % confidence intervals 
(CI) were determined. To assess the potential impact 
of the severity of LV diastolic dysfunction on progno-
sis, patients were divided based on quartiles of lateral E′ 
maximal velocity. A two-tailed p value <0.05 was consid-
ered statistically significant.
Results
Five hundred and forty patients were admitted to our 
ICU with a septic shock during the study period. In 
304 of them (56  %), echocardiography was not avail-
able due to the absence of digital recordings or to a low 
image quality precluding accurate measurements, and 
12 patients (2  %) failed to meet all diagnostic criteria 
of septic shock. Finally, 223 patients were included into 
the study (140 men [63  %]; age 64 ±  13  years; SAPS II 
55 ±  18; SOFA 10 ±  3; Charlson 3.5 ±  2.5) and 204 of 
them (91 %) were under invasive mechanical ventilation. 
The source of infection was documented in 185 patients 
(83  %), and a bacteremia was identified in 85 patients 
(38 %). Sepsis originated from intra-abdominal infection 
in 87 patients (39 %), a pulmonary infection in 48 patients 
(22 %), an urogenital infection in 37 patients (17 %) and 
a skin or joint and bones infection in 12 patients (5 %). 
Seventy-eight patients died in the ICU, accounting for a 
35 % mortality rate.
When compared with survivors, patients who died in 
the ICU had significantly higher SAPS II and SOFA scores 
and had more frequently an underlying hematologic 
malignancy (Table  1). No significant inter-group differ-
ence in infection characteristics was found. Patients who 
died in the ICU had significantly lower pH (7.27 ±  0.17 
vs. 7.32  ±  0.12: p  =  0.03), higher lactate (6.3  ±  5.3 vs. 
4.1  ±  3.7  mmol/L: p  =  0.0004) and creatinine levels 
(225 ± 144 vs. 180 ± 140 µmol/L: p = 0.03) and exhibited 
more frequently a disseminated intravascular coagulation 
(10/78 [13 %] vs. 11/145 [8 %]: p = 0.002) at the time of 
shock diagnosis than their counterparts (Table  1). The 
delay of initial antibiotic therapy was longer (4.3 ±  10.6 
vs. 1.8 ±  4.0  h: p =  0.02), and antibiotics were less fre-
quently appropriate (63/78 [81  %] vs. 135/145 [93  %]: 
p =  0.005) in non-survivors than in patients discharged 
alive from the ICU. Similarly, patients who died in the 
ICU received a greater dose of vasopressors (1.25 ± 1.17 
vs. 0.55 ± 0.47 µg/kg/min: p < 0.0001) than survivors and 
required more frequently the administration of epineph-
rine (35/78 [45  %] vs. 33/145 [23  %]: p =  0.0006), renal 
replacement therapy (19/78 [24  %] vs. 19/145 [13  %]: 
p  =  0.04) and mechanical ventilation (77/78 [99  %] vs. 
127/145 [88  %]: p =  0.0012) (Table  1). After initial fluid 
resuscitation, hemodynamic parameters were not sig-
nificantly different between groups (Table  2). While 
mean LVEF, mean LVEDV and mean ΔSVC were simi-
lar between groups, non-survivors exhibited slightly 
yet significantly lower LV stroke volume reflected by 
a decreased mean LVOT VTI (16  ±  6 vs. 17  ±  5  cm: 
p  =  0.03) and larger RV cavity, as reflected by a sig-
nificantly greater RVEDA/LVEDA ratio (0.77  ±  0.83 vs. 
0.59  ±  0.17: p  =  0.01) without associated paradoxical 
septal motion (Table  2). The prevalence of hyperkinetic 
LV (LVEF > 70 %) was low in the two study groups (2/78 
[3 %] vs. 10/145 [7 %]: p = 0.17). Actual LV dilatation was 
rarely observed, with the same frequency in both groups 
(8/78 [10 %] vs. 14/145 [10 %]: p = 0.89). Mean value of 
lateral E′ maximal velocity was significantly lower in 
patients who died in the ICU when compared with sur-
vivors (10.5 ± 3.7 vs. 11.9 ± 4.5 cm/s: p = 0.04), whereas 
mean E/E′ lateral only tended to be higher in those 
patients without reaching statistical significance (Table 2). 
The proportion of LV diastolic dysfunction tended to be 
higher in non-survivors than in their counterparts, even 
if the difference was not significant (28/78 [36  %] vs. 
41/145 [28 %]: p = 0.15). In the lower quartile of E′ lateral 
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maximal velocity values (E′ lateral ≤  8.2  cm/s), the pro-
portion of deceased patients tended to be higher, whereas 
the opposite trend was observed in the higher quartile (E′ 
lateral ≥ 14.1 cm/s) (Table 3).
In the multivariate analysis, the inappropriateness of 
initial antibiotic therapy, the maximal dose of vasopres-
sors during ICU stay, the SOFA score and E′ lateral maxi-
mal velocity (OR 1.12 [95 % CI 1.01–1.24] per decrease of 
Table 1 Clinical characteristics of the study population
Results are expressed as means ± standard deviations; numbers in brackets are percentages
SAPS II Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment, ALAT alanine aminotransferase, DIC disseminated intravascular coagulation
a During the ICU stay
Parameters Global population (n = 223) Survivors (n = 145) Non-survivors (n = 78) p
Patients characteristics
Age (years) 64 ± 13 63 ± 13 64 ± 13 0.74
Male (n) 140 (63) 93 (64) 47 (60) 0.57
SAPS II 55 ± 18 49 ± 15 66 ± 17 <0.0001
SOFA 10 ± 3 9 ± 3 11 ± 3 <0.0001
Charlson 3.5 ± 2.5 3.4 ± 2.6 3.6 ± 2.1 0.56
Cancer (n) 35 (16) 23 (16) 12 (15) 0.93
Hematologic malignancy (n) 10 (4) 1 (0.7) 9 (12) 0.0004
Chronic renal failure (n) 14 (6) 7 (5) 7 (9) 0.22
Cirrhosis (n) 12 (5) 5 (3) 7 (9) 0.08
Infection characteristics
Documented infection 185 (83) 123 (85) 62 (80) 0.31
Bacteremia 105 (47) 65 (45) 40 (51) 0.36
Abdominal 87 (39) 57 (41) 30 (41) 0.96
Pulmonary 48 (22) 31 (22) 17 (23) 0.94
Urogenital 37 (17) 26 (19) 11 (15) 0.46
Skin or joint and bones 12 (5) 1 (7) 3 (4) 0.14
Other origin 30 (13) 16 (13) 13 (15) 0.21
Biology
pH 7.30 ± 0.14 7.32 ± 0.12 7.27 ± 0.17 0.03
Lactates (mmol/L) 4.9 ± 4.4 4.1 ± 3.7 6.3 ± 5.3 0.0004
PaO2/FiO2 177 ± 113 180 ± 116 171 ± 108 0.57
Creatinine (µmol/L) 196 ± 143 180 ± 140 225 ± 144 0.03
Bilirubin (µmol/L) 22 ± 35 20 ± 24 27 ± 49 0.12
ALAT (IU/L) 134 ± 335 115 ± 302 167 ± 389 0.28
Hemoglobin (g/dL) 11 ± 2 11 ± 2 11 ± 3 0.69
White blood cells (G/L) 15.5 ± 14.5 15.5 ± 12.3 15.6 ± 18.1 0.93
Platelets (G/L) 211 ± 151 217 ± 157 199 ± 138 0.40
DIC (n) 21 (9) 11 (8) 10 (13) 0.002
Treatment characteristics
Delay of antibiotic therapy (h) 2.7 ± 7.1 1.8 ± 4.0 4.3 ± 10.6 0.02
Antibiotics administered <3 h 174 (78) 119 (84) 55 (71) 0.06
Appropriate initial antibiotic therapy 198 (88) 135 (93) 63 (81) 0.005
Fluid therapy (L) 4.4 ± 3.7 4.4 ± 3.6 4.6 ± 3.9 0.74
Noradrenaline (n) 205 (92) 134 (95) 71 (91) 0.72
Epinephrine (n) 68 (30) 33 (23) 35 (45) 0.0006
Dobutamine (n) 11 (5) 6 (4) 5 (6) 0.45
Maximal dose of vasopressorsa (µg/kg/min) 0.79 ± 0.85 0.55 ± 0.47 1.25 ± 1.17 <0.0001
Hydrocortisone Hemisuccinate (n) 22 (10) 11 (8) 11 (14) 0.12
Renal replacement therapy 38 (17) 19 (13) 19 (24) 0.04
Invasive mechanical ventilation 204 (91) 127 (88) 77 (99) 0.0012
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1 cm/s; p = 0.02) were significantly associated with ICU 
mortality (Table 4). After adjusting for the SAPS II score, 
the initial inappropriate antibiotic therapy and the maxi-
mal dose of vasopressors remained independent factors 
related to ICU mortality. In contrast, a trend was only 
observed for lateral E′ maximal velocity (OR 1.11 [CI 
95 % 0.99–1.23]: p = 0.07) (Table 4).
Discussion
In the present study, independent factors related to ICU 
mortality in septic shock patients were the inappropri-
ate initial antibiotic therapy, the maximal dose of vaso-
pressors used during ICU stay, the SOFA score and a 
decreased lateral E′ maximal velocity indicating altered 
LV diastolic properties. After adjusting for the SAPS 
II score, inappropriate antibiotic therapy and maximal 
dose of vasopressors were the sole factors independently 
associated with ICU mortality, while a trend was only 
observed for lateral E′ maximal velocity.
LV diastolic dysfunction was observed in 31  % of our 
patients, in keeping with the prevalence reported previ-
ously in patients hemodynamically assessed for severe 
sepsis and septic shock, which ranged between 20 % [15, 
16] and 57 % [33]. Such variations may be related to the 
use of different definitions for LV diastolic dysfunction, 
Table 2 Hemodynamic parameters and echocardiographic findings at the time of assessment
Results are expressed as means ± standard deviations; numbers in brackets are percentages
sBP systolic blood pressure, mBP mean blood pressure, dBP diastolic blood pressure, HR heart rate, CVP central venous pressure, LVEF left ventricular ejection fraction, 
LVEDV left ventricular end-diastolic volume, LVOT VTI left ventricular outflow tract velocity–time integral, RVEDA right ventricular end-diastolic area, LVEDA left 
ventricular end-diastolic area, ΔSVC collapsibility index of the superior vena cava
Parameters Global population (n = 223) Survivors (n = 145) Non-survivors (n = 78) p
Hemodynamic parameters
sBP (mmHg) 112 ± 29 113 ± 28 109 ± 31 0.34
dBP (mmHg) 63 ± 17 64 ± 16 62 ± 18 0.36
mBP (mmHg) 77 ± 20 78 ± 19 75 ± 22 0.35
HR (bpm) 109 ± 25 107 ± 24 112 ± 27 0.19
CVP (mmHg) 11 ± 5 11 ± 5 11 ± 6 0.72
Echocardiography
LVEF (%) 48 ± 17 49 ± 17 46 ± 18 0.39
LVEDV (mL) 93 ± 36 95 ± 37 90 ± 34 0.37
LVOT VTI (cm) 16 ± 5 17 ± 5 16 ± 6 0.03
E wave (cm/s) 80 ± 27 80 ± 25 79 ± 30 0.49
A wave (cm/s) 82 ± 27 82 ± 27 82 ± 27 0.89
E/A 1.03 ± 0.55 1.05 ± 0.58 0.99 ± 0.46 0.85
Lateral E′ wave (cm/s) 11.4 ± 4.3 11.9 ± 4.5 10.5 ± 3.7 0.04
E/E′ lateral 8.0 ± 3.8 7.7 ± 3.7 8.5 ± 4.0 0.26
RVEDA/LVEDA 0.66 ± 0.51 0.59 ± 0.17 0.77 ± 0.83 0.01
Paradoxical septal motion (n) 14 (6) 7 (5) 7 (9) 0.23
ΔSVC (%) 14 ± 13 15 ± 13 14 ± 12 0.97
Table 3 Distribution of  patients according to  quartiles 
of lateral E′ maximal velocity






Lateral E′ ≥ 14.1 cm/s 31 (21) 11 (14) 0.14
10.9 ≥ lateral E′ < 14.1 cm/s 30 (21) 13 (17)
8.2 ≥ lateral E′ < 10.9 cm/s 17 (12) 13 (17)
8.2 ≥ lateral E′ < 14.1 cm/s 21 (14) 20 (26)
Table 4 Multivariate analysis to determine prognostic fac-
tors associated with ICU mortality
SOFA Sequential Organ Failure Assessment, SAPS Simplified Acute Physiology 
Score
Parameters Odds ratio [95 % CI] p
Without adjustment
Inappropriate initial antibiotic therapy 4.17 [1.33–12.5] 0.03
Maximal dose of vasopressors (per mg/h) 1.38 [1.16–1.63] 0.01
SOFA (per point) 1.16 [1.02–1.32] 0.02
Lateral E′ maximal velocity (per decrease 
of 1 cm/s)
1.12 [1.01–1.24] 0.02
When adjusting for SAPS II
Inappropriate initial antibiotic therapy 5.88 [1.64–20.00] 0.007
Maximal dose of vasopressors (per mg/h) 1.26 [1.08–1.47] 0.004
Lateral E′ maximal velocity (per decrease 
of 1 cm/s)
1.11 [0.99–1.23] 0.07
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different timing of echocardiographic assessment rela-
tive to the sepsis course, and distinct clinical settings 
(i.e., severe sepsis vs. septic shock). Using the currently 
recommended criteria [32], we and others previously 
identified a reversible LV diastolic dysfunction in 20 % of 
septic shock patients [15, 16]. The marked smaller sam-
ple size of these previous studies when compared with 
the present cohort may account for this discrepancy. 
The current study confirms that true LV enlargement is 
uncommon in septic shock patients [15, 34]. The poten-
tial protective effect of LV cavity dilatation on outcome 
has long been suggested in septic patients [7]. Its prog-
nostic significance is currently debated and remains to 
confirm in large-scale studies [35].
Measurement of tissue Doppler E′ wave maximal 
velocity at the mitral annulus reflects the lengthen-
ing velocity of LV longitudinal myocardial fibers during 
early diastole. Accordingly, a reduced E′ velocity <8 cm/s 
when measured on septal mitral annulus and <10  cm/s 
when measured on lateral mitral annulus are diagnostic 
of LV diastolic dysfunction [32]. We previously showed 
the high precision of this measurement in critically 
ill patients, as reflected by a 4 and 2 % inter- and intra-
observer reproducibility, respectively [29]. Accordingly, 
the small absolute difference in lateral E′ maximal veloci-
ties observed between groups in the current study is 
greater than expected reproducibility of measurement. 
We purposely measured E′ maximal velocity on the lat-
eral aspect of the mitral annulus because we previously 
found that this parameter was relatively independent of 
LV loading conditions, as opposed to septal E′ maximal 
velocity [29]. Nevertheless, Mahjoub et  al. [36] recently 
reported that the increase in E′ maximal velocity sec-
ondary to fluid loading was significantly greater in septic 
patients with fluid responsiveness, whereas non-respond-
ers to a fluid challenge exhibited larger increase in E/E′ 
ratio reflecting higher LV filling pressure after blood vol-
ume expansion. In our patients, mean ΔSVC, which has 
previously been validated as a marker of fluid responsive-
ness [31], was similar in survivors and in non-survivors. 
Moreover, mean fluid volume administered to our septic 
patients prior to hemodynamic assessment was also simi-
lar in both groups. Accordingly, fluid resuscitation has 
presumably not influenced lateral E′ maximal velocity in 
the present cohort of septic shock patients.
Although LV diastolic dysfunction alters the prognosis 
of many cardiac diseases [12, 13], its prognostic impact in 
septic shock remains controversial. Several studies failed 
to identify LV diastolic dysfunction as a potential predic-
tor of outcome in septic patients [10, 15]. In contrast, a 
recent meta-analysis reported a relationship between 
abnormal LV relaxation as assessed by E′ maximal veloc-
ity and death in septic patients [17]. In a cohort of 262 
patients with severe sepsis and septic shock, Landesberg 
et  al. [9] showed that LV diastolic dysfunction was the 
strongest predictor of short-term mortality, even after 
adjusting for the APACHE II score. ICU mortality was 
also related to the severity of LV diastolic dysfunction [9]. 
In keeping with these results, lateral E′ maximal veloc-
ity was independently associated with ICU mortality in 
our septic shock patients. Nevertheless, a nonsignifi-
cant trend only persisted when adjusting for the SAPS II 
score and was observed when dividing the current cohort 
according to quartiles of lateral E′ maximal velocity. A 
similar trend was observed when using a cutoff value of 
10  cm/s for defining LV diastolic dysfunction [32] and 
when comparing its prevalence between non-survivors 
and survivors. The potential impact of LV diastolic dys-
function on ICU mortality of septic shock patients may 
be related to various factors. Abnormal relaxation results 
in a reduced early LV filling, an increased contribution of 
left atrial contraction to late LV filling and a progressive 
increase in LV filling pressure [14]. Marked hypovolemia, 
tachycardia and high rate of acute atrial fibrillation in 
sepsis [37] contribute to further reduce early LV filling 
by shortening the duration of diastole and subsequently 
to decrease cardiac output. The relative increase in LV 
filling pressures associated with diastolic dysfunction 
could facilitate a positive fluid balance, which prognos-
tic impact has recently been suggested [38, 39]. This may 
worsen non-cardiogenic pulmonary edema associated 
with sepsis [40], or even lead to right cardiac failure [18], 
as suggested by the increased RVEDA/LVEDA ratio with-
out associated acute cor pulmonale in our patients who 
died in the ICU.
As previously reported [26], inappropriate initial anti-
biotic therapy was the strongest predictor of ICU mortal-
ity in the present cohort of septic shock patients. In our 
patients, the 4.17 odds ratio for ICU death was in agree-
ment with the fivefold higher risk of death observed by 
Kumar et  al. [26]. Inappropriate initial antibiotic ther-
apy remained significantly associated with ICU mor-
tality after adjusting for SAPS II score with a 5.88 odds 
ratio. In addition to the SOFA score, the maximal dose 
of vasopressors administered to our septic shock patients 
was also an independent risk factor for ICU mortal-
ity. Higher mean dose of vasopressors administered to 
non-survivors may reflect the presence of a more severe 
circulatory failure with profound vasoplegia, which has 
long been related to unfavorable outcome [7]. Higher 
mortality rate in septic shock patients presenting with 
a hyperkinetic hemodynamic profile associating mark-
edly increased cardiac output and low systemic vascular 
resistance has also been reported in echocardiographic 
studies [34, 41]. In our patients, mean LVEF was similar 
between survivors and non-survivors, and the prevalence 
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of hyperkinetic profile was not significantly different 
between groups. The low prevalence of marked hyperki-
netic states reflected by a LVEF  >  70  % in septic shock 
patients presumably explains this result due to our 
underpowered study [34]. Nevertheless, currently avail-
able studies have been conducted on limited sample 
size [7, 34], or failed to enroll consecutive patients [41]. 
Accordingly, the prognostic value of LV hyperkinesia as 
a marker of profound sepsis-induced vasoplegia remains 
to confirm in a large prospective cohort of consecutive 
patients with septic shock who are hemodynamically 
assessed using echocardiography.
Although various other factors have been shown to 
be prognostic in patients with septic shock, including 
comorbidities [42], site of infection [43], bacteriological 
documentation [44], causative microorganism [45] and 
initial management [25], none of these factors was asso-
ciated with ICU mortality in the present cohort of septic 
shock patients.
The present study has several limitations. Due to its 
retrospective design, the absence of available echocardio-
graphic recordings in a substantial proportion of eligible 
patients constitutes a selection bias. Nevertheless, our 
cohort appears representative of septic shock patients 
admitted to the ICU, with a 35 % mortality rate [1, 2], a 
large proportion of patients under ventilator [43, 44] 
and a mean SOFA score of 10 reflecting the presence of 
sepsis-induced multiple organ failure [44]. Since LV dias-
tolic dysfunction is commonly associated with age, high 
blood pressure, diabetes and ischemic heart disease, it 
may be present prior to the development of septic shock 
in a large proportion of patients, rather that induced by 
sepsis [14]. The potential worsening of LV diastolic func-
tion secondary to the development of septic shock and 
its reversibility with the control of the causative infec-
tion could not be documented in the present study since 
echocardiography was not serially performed. Neverthe-
less, no prospective study has yet repeatedly assessed 
LV diastolic properties in a large cohort of septic shock 
patients. Accordingly, only few information on the course 
of LV diastolic properties during the management of sep-
tic shock is currently available, and the reversibility of 
sepsis-induced LV diastolic dysfunction remains to be 
confirmed [15, 16]. Since septal E′ maximal velocity was 
not measured in our patients, we could not use the tra-
ditional diagnostic criteria of LV diastolic dysfunction 
based on mean septal and lateral E′ maximal velocities 
and mean E/E′ ratio [32]. Nevertheless, E′ maximal veloc-
ity appears to be less dependent of LV loading conditions 
when recorded at the lateral rather than at the septal 
mitral annulus [29]. Finally, the dose of vasopressors and 
inotropes which may have altered LV diastolic properties 
at the time of echocardiographic assessment has not 
been recorded.
Conclusion
The present study confirms the frequency of LV diastolic 
dysfunction at the initial phase of septic shock. LV dias-
tolic function assessed by the measurement of lateral E′ 
maximal velocity was independently associated with ICU 
mortality, in conjunction with the inappropriateness of 
the initial antibiotic therapy, the maximal dose of vaso-
pressors administered and the SOFA score. After adjust-
ing for the SAPS II score, a nonsignificant trend was only 
observed for E′ lateral maximal velocity. Due to the ret-
rospective design of the present study and limitations of 
currently reported series, a prospective multicenter study 
allowing the longitudinal assessment of a large cohort of 
patients with septic shock using serial echocardiographic 
examinations is required to definitely confirm the poten-
tial prognostic role of LV diastolic dysfunction in this 
highly prevalent disease.
Key messages
  • Left ventricular diastolic dysfunction is frequently 
observed in ICU patients who are hemodynamically 
assessed using echocardiography for a septic shock.
  • Left ventricular diastolic function assessed using 
lateral E′ maximal velocity was independently asso-
ciated with ICU death in conjunction with inap-
propriate initial antibiotic therapy, maximal dose of 
vasopressors and SOFA score.
  • After adjusting for SAPS II score, only a nonsignifi-
cant trend was observed between lateral E′ maximal 
velocity and ICU mortality.
  • A large-scale multicenter study is needed to definitely 
confirm the prognostic role of left ventricular dias-
tolic dysfunction in septic shock patients.
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